Interactions Between Glutamate Receptors and TRPV1 Involved in Nociceptive Processing at Peripheral Endings of Primary Afferent Fibers by You-Hong Jin et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
  
2 
Interactions Between Glutamate  
Receptors and TRPV1 Involved in  
Nociceptive Processing at Peripheral  
Endings of Primary Afferent Fibers 
You-Hong Jin1, Motohide Takemura2,  
Akira Furuyama3 and Norifumi Yonehara4 
1Department of Anatomy the Affiliated Stomatological,  
Hospital of Nanchang University, Nanchang, Jiangxi Province, 
2Department of Oral Anatomy and Neurobiology,  
Osaka University Graduate School of Dentistry,  
 3Departments of Oral Physiology  
4Oral Medical Science (Division of Dental Pharmacology), 
 Ohu University School of Dentistry, Koriyama, Fukushima,  
1China  
2,3,4Japan   
1. Introduction 
Glutamate (Glu) is a main excitatory neurotransmitter in the central nervous system. 
Concerning the existence of Glu in the small-diameter afferent fibers, their central 
(Westlund et al., 1989; Keast and Stephensen, 2000) and peripheral (Westlund et al., 1992; 
Keast and Stephensen, 2000) processes as well as dorsal root ganglion (DRG) cells 
(Battaglia and Rustioni, 1988; Keast and Stephensen, 2000) contain Glu. Recently, Glu has 
been shown to have a role in transduction of sensory input at the periphery (Carlton, 
2001).  
Electron microscope studies demonstrate that Glu receptors are transported from the DRG 
cell bodies into central and/or peripheral primary afferent terminals (Liu et al., 1994). The 
N-methyl-D-aspartic acid (NMDA), -amino-3-hydroxy-5methyl-4-isoxazole propionic acid 
(AMPA) and kainate receptors (NMDA/AMPA-kainate receptors) are localized on 
unmyelinated axons at the dermal-epidermal junction in the glabrous and hairy skin of the 
rat (Carlton et al., 1995; Coggeshall and Carlton, 1998), and in human hairly skin (Kinkelin et 
al., 2000). Approximately 20% of the fibers were immunostained in one of the receptor 
subtypes. As Sato et al. (1993) reported that virtually all DRG cells as well as their central 
(Laurie et al., 1995; Zou et al., 2002) and peripheral (Carlton et al., 1995) processes are 
positively labeled for the NMDA receptor, it is highly likely that two or more of the 
ionotropic Glu receptors are colocalized.  
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Behavioral evidence supports a role for peripheral Glu receptors in normal nociceptive 
transmission. Intraplantar injection of L-Glu into the hindpaw evokes hyperalgesia in rats 
(Follenfant and Nakamura-Craig, 1992; Carlton et al., 1995). Futhermore, intraplantar 
injection of the specific Glu receptors agonists NMDA, AMPA or kainate results in 
mechanical hyperalgesia and allodynia that can be blocked by appropriate antagonists 
(Zhou et al., 1996). Hyperalgesia is induced by binding the released glutamate to NMDA 
receptor (Leem et al., 2001; Du et al., 2003), group I mGluR (Bhave et al., 2001; Zhou et al., 
2001; Hu et al., 2002; Walker et al., 2001; Lee et al., 2007), but not group II mGluR (Yang and 
Gereau IV, 2003).  
In addition to these behavioral and anatomical data, Omote et al. (1998) showed that 
subcutaneous administration of inflammatory substances such as formalin induced the 
release of peripheral EAAs (Glu and aspartate) on the ipsilateral side. We have already 
reported that local application of capsaicin cream evoked a marked increase in Glu level in 
the s.c. perfusate. In addition, electrical stimulation of the sciatic nerve or noxious heat 
stimulation (50C) also caused increase of Glu level in the s.c. space, and this capsaicin-
evoked Glu release was significantly decreased by daily high-dose pretreatment with 
capsaicin for three consecutive days (Jin et al., 2006). 
The capsaicin receptor, transient receptor potential vanilloid 1 (TRPV1), is located in a 
neurochemically heterogeneous population of small diameter primary afferent neurons 
(Tominaga et al., 1998). This receptor is sensitive to high temperature in the noxious range of 
43°C to 50°C (Hardy, 1953; Beitel and Dubner, 1976; Caterina et al., 1997). Furthermore, 
repeated exposure to high-dose capsaicin selectively produces a prolonged influx of cations 
leading to desensitization of small-diameter sensory neurons to subsequent noxious 
stimulation (Yonehara et al., 1987; Lynn, 1990; Zhou et al., 1998; Caterina and Julius, 2001), 
while myelinated Afibers are insensitive to capsaicin (Jancso et al., 1977; Nagy et al., 1983; 
Michael and Priestly, 1999).  
There is an evidence suggesting possibility that capsaicin-evoked pain responses might be 
regulated by peripheral GluRs. In this connection, Lam et al. (2005) demonstrated that 
peripheral NMDA receptor modulate jaw muscle electromyographic activity induced by 
capsaicin injection into the temporomandibular joint of rats. 
This study, therefore, has been done to elucidate at large in what manner Glu receptors and 
Glu existing in the peripheral endings of small-diameter afferent fibers and their 
extracellular space, respectively, are involved in development and/or maintenance of 
nociception evoked by capsaicin. Additionally, in order to demonstrate a link between the 
increase of Glu levels in the extracellular space following noxious stimulation and pain 
behavior, the changes in thermal withdrawal latency and the expression of c-Fos protein in 
the dorsal horn were determined following subcutaneous (s.c.) injection of drugs associated 
with Glu receptors with/without capsaicin. 
2. Materials and methods 
All surgical and experimental procedures for animals were reviewed and approved by the 
Ohu University Intramural Animal Care and Use Committee and conformed to the 
guidelines of the International Association for the Study of Pain (Zimmermann, 1983). 
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2.1 Experimental procedures 
Adult male Sprague-Dawley rats weighing between 200-300 g (CLEA Japan, INC. Tokyo, 
Japan) were used in all experiments. Rats were on a 12 hrs light/dark cycle and received 
food and water ad libitum. 
2.2 Release of Glu into the subcutaneous space 
Animals were anesthetized with urethane (1 g/kg i.p.). A single loop catheter whose tip was 
covered with a 5000 molecular weight dialysis membrane (MS 0045, PSS® SELECT, Florida) 
was introduced into the s.c. space of the instep using a 2.2 mm outer diameter polyethylene 
tube as a guide. Ringer’s solution was perfused at 15 l/min through this catheter with a 
micro syringe pump (EP-60, Eicom, Kyoto, Japan) and perfusate was collected into the tubes 
placed in an ice bath at intervals of 20 min. The samples were kept at -80°C until analysis.  
2.3 Amino acid analysis 
Amino acids in the dialysate were analyzed by a high-performance liquid chromatography 
(HPLC) system for automated analysis of amino acids using o-phthalaldehyde 
derivatization and fluorescence detection. Amino acids were quantified by reverse-phase 
chromatography using a C18 octadecylsilyl (ODS) silica-gel column (EICOMPAK SC-50DS 
2.1 mm x 150 mm) with pre-column (EICOM PREPAKSET-AC 3 mm x 4 mm). An HPLC 
system (HTEC500, EICOM) attaching this column consists of a pump connected with a 
degasser, a sampling injector with a sample processor and a cool pump, a fluorescence 
HPLC monitor and a personal computer with the data processor (Power Chrom; EPC-500, 
EICOM). The mobile phase used for separation of amino acids was 100 mM, pH 6 phosphate 
buffer containing 30% methanol and 10 M EDTA. The flow rate was 0.23 ml/min. Peak 
areas of unknown substances were compared to those of control compounds for 
quantitation. 
To determine the effect of drugs on the level of Glu, the average amounts of Glu 
concentration in two 20-min fractions collected over periods of 40 min before and after local 
application of capsaicin cream were obtained and expressed as percentages of the control 
value before stimulation.  
2.4 Drug administration 
While the animals were inside the small cage, drugs were administered into the s.c. left 
hindpaw in a volume of 50 l using a 100 l Hamilton syringe (Reno, NV, USA) with a 30-
gauge needle without any anesthesia. The needle was inserted into the plantar skin 
proximal to the midpoint of the hindpaw. Capsazepine (30mg/kg) was injected in the 
volume of 50 l into the s.c. of the neck. 
2.5 Behavioral assessments 
The Plantar Test (model 7370; Ugo Basile, Verese, Italy) was used in accordance with 
previously described methods (Yonehara et al., 1997) to determine whether the rats were 
hyperalgesic. In brief, prior to testing, the animals were placed in a small cage on a glass 
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plate. They were not restrained and could move about and explore freely. Radiant heat was 
beamed onto the plantar surface of the hindpaw. The intensity of the beam was controlled 
and adjusted prior to the experiments, and the cutoff latency was set at 24 sec. The beam 
was applied to the test and control foot in turns and the latency of the withdrawal reflexes 
was recorded. The mean of the four responses was determined (Figs 4-8), and the ratio of 
the test foot latency divided by control foot latency, multiplied by 100, was calculated and 
termed the “percentage withdrawal latency” (Fig.3), at hourly intervals, from 1 hr before 
injection of the drugs to 6 h after the injection, except for 15 min after the injection 
2.6 c-Fos immunohistochemistry 
Two hours after the drug injection, animals were deeply anesthetized with sodium-
pentobarbital and perfused transcardially with 100ml of 0.9% saline followed by 500 ml of 
4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4) and the spinal cord was taken 
out, postfixed in the same fixative overnight at 4°C, and then immersed into 20% sucrose in 
0.1M PB at 4°C until it sank. Serial transverse 60 µm thick sections at L4-6 were cut using a 
freezing microtome and collected in 0.02 M phosphate buffered saline (PBS). Sections were 
washed in PBS for 30 min and blocked with 1% normal goat serum for 30 min and then 
incubated in a rabbit antibody against c-Fos (1:7000 dilution; Santa Cruz Biotech, Santa 
Cruz, CA, USA) for 60 min in room temperature and then for 12 hrs at 4°C. After washing in 
PBS for 30 min, sections were incubated in biotinylated goat anti-rabbit antiserum, and 
washed in PBS for 30 min and then immunohistochemically stained for 60 min using avidin-
biotin-peroxidase complex (Vectastain, Vector Laboratories, Burlingame, CA, USA). To 
visualize peroxidase activity, sections were immersed in 0.05% diaminobenzidine 
tetrahydrochloride, 0.1% ammonium nickel sulfate and 0.01% hydrogen peroxide in 0.05 M 
Tris-HCl buffer (pH 7.2). Sections were washed in PBS for 30 min and then mounted on 
gelatin-coated slides, air-dried and coverslipped. The c-Fos-immunoreactive cells of 10 best-
labeled sections were counted in the L5 spinal dorsal horn. In all these tests a double blind 
procedure was used to prevent the observers from knowing the experimental groups. 
2.7 Drugs 
The list of drugs and chemicals were as follows: as Glu receptors agonist, L-glutamic acid; 
selective NMDA receptor agonist, NMDA; AMPA receptor agonist, -amino-3-hydroxy-4-
isoxazoleproprionic acid (AMPA); selective group 1 mGlu receptor agonist, (S)-3,5- 
dihydroxyphenylglycine ((S)-3,5-DHPG); group II mGlu receptor agonist, (2S,1’S,2’S)-2-
(carboxycyclopropyl) glycine (L-CCG-I); selective group III mGlu receptor agonist,  
L-(+)-2-amino-4-phosphonobutyric acid (L-AP4). The following drugs were used for Glu 
receptors antagonists, selective non-competitive NMDA receptor antagonist, (5S,10R)-(+)-5-
Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclo-hepten-5, 10-imine hydrogen maleate  
((+)-MK-801 hydrogen maleate); competitive kainite/AMPA receptor antagonist,  
6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX) and 2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX); group 1 mGlu  
receptor selective non-competitive mGlu1 receptor antagonist, 7-(hydroxyimino) 
cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt); group 1 mGlu receptor mGlu5 
subtype-selective antagonist, 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP); 
group II mGlu receptor antagonist, ((2S,3S,4S)-2-methyl-2-(carboxycyclopropyl)glycine 
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(MCCG); selective group III mGlu receptor antagonist, (RS)-α-methylserine-O-phoephate 
(MSOP). These compounds of Glu receptors were obtained from Tocris (Ballwin, MO, USA). 8-
Methyl-N-vanillyl-6-noneamide (capsaicin) was obtained from Sigma Chemical Co. (USA). All 
other chemicals were obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).  
In accordance with the product material safety data sheets, L-glutamate acid, L-CCG-I and 
L-AP4 were diluted in NaOH; and MK801, NMDA, (S)-3, 5,-DHPG, MCCG and MSOP were 
diluted in water. CNQX, CPCCOEt and MPEP were diluted in dimethyl sulphoxide. The 
other drugs except for these were dissolved in saline. Capsaicin was prepared as a 10 
mg/ml solution in saline containing 10% ethanol and 10% Tween 80. The pH of all solutions 
was adjusted to 7.4. Capsazepine was dissolved in dimethyl formamide and then diluted 
with saline. O-phthalaldehyde was dissolved in methanol and adjusted to 4 mM with 0.1 M, 
pH 9.5 carbonate buffer.  
2.8 Statistical analysis 
All data are shown as mean ± S.E.M. In the study of Glu release, statistical analyses were 
performed using posthoc test of Fisher’s protected least significant difference and P<0.05 
was considered to be statistically significant. In the behavioral study, statistical analyses 
were performed with Dunnett’s test for multiple comparison subsequent to analyses of 
variance. In the c-Fos immunohistochemichal study, a Student’s test was used to test 
significant differences of the c-Fos expression between the treatments. 
2.9 Abbreviations 
AMPA-amino-3-hydroxy-4-isoxazole proprionic acid, Cap+MK801; Capsaicin combined 
with MK801, Cap+CNQX; Capsaicin combined with CNQX, Cap+NBQX; Capsaicin combined 
with NBQX, Cap+CPCCOEt; Capsaicin combined with CPCCOEt, Cap+MCCG; Capsaicin 
combined with MCCG, Cap+MSOP; Capsaicin combined with MSOP, CNQX; 6-Cyano-7-
nitroquinoxaline-2,3-dione disodium, CPCCOEt; 7-(hydroxyimino) cyclopropa[b]chromen-1a-
carboxylate ethyl ester, (S)-3,5-DHPG; (S)-3,5- dihydroxyphenylglycine, DRG; dorsal root 
ganglion, Glu, glutamate; L-CCG-I; (2S,1’S,2’S)-2-(carboxycyclopropyl) glycine, L-AP4; L-(+)-2-
amino-4-phosphonobutyric acid, MCCG; (2S,3S,4S)-2-methyl-2-(carboxycyclopropyl) glycine, 
mGluRs; metabotropic glutamate receptors, (+)-MK-801; (5S,10R)-(+)-5-Methyl-10,11-dihydro-
5H-dibenzo[a,d] cyclo-hepten-5, 10-imine hydrogen maleate, MPEP; 2-Methyl-6-
(phenylethynyl) pyridine hydrochloride, MSOP; (RS)-α-methylserine-O-phoephate, NBQX; 
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt, NMDA; 
N-methyl-D-aspartic acid. 
3. Results 
3.1 Basal Glu release 
The concentration of Glu in the perfusate was initially high, but gradually decreased with 
time reaching a stable level after 2 hrs of perfusion, which was then maintained for at least 
4.5 h. Glu was present at 1.95 ± 0.25 M (n=10, S.E.M.) in the resting state which is defined 
here as the mean of the two 20-min fraction collected from 80 min after starting perfusion to 
120 min (fraction 5~6 in control group in Fig.1). 
www.intechopen.com
 Pharmacology  
 
48
3.2 Effects of capsazepine on capsaicin-evoked Glu release 
The s.c. injection of capsaicin (3 mM) in the vicinity of the perfusion side evoked a 
significant increase in Glu release (Fig.1). The average concentration of the released Glu 
was 4.86 ± 0.48 M/20 min in 2 fractions collected after the injection of capsaicin. This 
augmentation of Glu release was last over 2 h. This effect was remarkably suppressed by 
preadministration of capsazepine (30 mg/kg, s.c.) 30 min before capsaicin injection 
(Fig.1). In the group of pretreatment with capsazepine, the average concentrations of the 
released Glu were 2.25 ± 0.4 M/20 min and 2.36 ± 0.31 M/20 min in 2 fractions collected 
after the injection of vehicle or capsaicin, respectively. S.c. injections of vehicle or 
capsazepine  alone did not produce any significant changes in the levels of Glu in the 
perfusates. 
 
Fig. 1. Effect of capsazepine on the capsaicin-induced glutamate release. Capsazepine (s.c.) 
was injected subcutaneously into the neck 30 min before capsaicin treatment. Capsazepine 
(30 mg/kg) or vehicle for capsazepine, and capsaicin (3 mM) or vehicle for capsaicin were 
subcutaneously injected at the time indicated by the arrows, (   ) and (   ), respectively. All 
data are presented as the mean ± S.E.M. obtained from 10 animals. #P<0.05 compare with 
the value prior to s.c. administration of capsaicin+vehicle. *P<0.05 compared with 
capsaicin+vehicle (for capsazepine) group at each time measured. 
3.3 Effects of iGluRs antagonists injection on capsaicin-evoked Glu release 
The combined injection of capsaicin with MK801(1 mM) (Cap + MK-801) or NBQX (5 mM) 
(Cap + NBQX) into the perfusion region showed far less Glu release than injection of 
capsaicin alone (Fig 2-A). The average concentration of the released Glu was 1.20 ± 0.1 M/ 
20 min or 1.70 ± 0.1 M/ 20min in 2 fractions collected after the co-injection of MK-801 or 
NBQX with capsaicin, respectively. These inhibitory effects of iGluRs antagonists sustained 
over 2.5 h. 
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Fig. 2. Effect of the ionotropic (A) and metabotropic (B) glutamate receptor antagonists on 
the capsaicin-induced glutamate release. The glutamate receptor antagonists were 
subcutaneously injected together with capsaicin at the time indicated by the arrow. All data 
are presented as the mean ± S.E.M. obtained from 10 animals. #P<0.05 compare with the 
value prior to s.c. administration of capsaicin+vehicle. *P<0.05 compared with 
capsaicin+vehicle group at each time measured. MK801, selective non-competitive NMDA 
receptor antagonist; NBQX, competitive kainate/AMPA receptor antagonist; CPCOOEt, 
group 1 mGlu receptor selective non-competitive mGlu1 receptor antagonist; MCCG, group 
II mGlu receptor antagonist; MSOP, selective group III mGlu receptor antagonist. 
3.4 Effects of mGluRs antagonists injection on capsaicin-induced Glu release 
At the doses employed, CPCCOEt (5 mM) (Cap + CPCCOEt) showed remarkable inhibition 
in capsaicin-evoked Glu release. The average concentration of the released Glu was 1.46 ± 
0.1 M/ 20 min after the co-injection of CPCCOEt with capsaicin. S.c. combined injection of 
MCCG (5 mM) (Cap + MCCG) or MSOP (5 mM) (Cap + MSOP) with capsaicin did not show 
significant decrease in Glu release compared to capsaicin injection alone. The average 
concentration of the released Glu was 3.68 ± 0.38 M / 20 min or 4.31 ± 0.60 M/ 20min in 2 
fractions collected after the co-injection of MCCG or MSOP with capsaicin, respectively. 
(Fig. 2-B) 
3.5 Effects of capsazepine on capsaicin-induced thermal hypersensitivity 
The mean withdrawal latencies to stimulation with radiant heat at pre-injection were 11.2 ± 
0.3 s and 11.2 ± 0.3 s (n=40) on the left and right side, respectively (Fig.3-A). The withdrawal 
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latency did not significantly change after injection of vehicle or low dose of capsaicin (0.6 
mM). A quarter and one h after injection of capsaicin (3 mM and 6 mM), withdrawal latency 
to irradiation decreased to much shorter than that of vehicle injection, which was recorded 
at the same interval (P<0.05), and then recovered gradually to the level of vehicle injection 
by 4 h after injection of capsaicin. Pretreatment of capsazepine (30 mg/kg, s.c.) produced a 
marked inhibition against capsaicin-induced thermal hyperalgesia (Fig.3-B). We did not 
observed any signs of motor deficiency or other side effects for any of the doses of any 
drugs in all paradigms described here and below. 
 
 
Fig. 3. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of capsaicin, and co-injection of capsazepine with capsaicin. The data for each 
group (10 animals) are presented as the means ± S.E.M. The withdrawal latency per animal 
at respective time points was calculated as the average of the latencies obtained from 3 
consecutive stimuli applied at intervals of 5 min. The value at time zero (pre) was obtained 1 
h prior to s.c. injection of capsaicin. * and # P<0.05 significantly different from vehicle-
treated group and capsaicin-treated group (3 mM), respectively.  
3.6 Thermal sensitivity after injection of iGluRs agonists 
S.c. injections of Glu, NMDA or AMPA produced dose-dependent decreases in 
withdrawal latency on the ipsilateral side 15 min after s.c. injection, and lasted for a few 
hours (Fig. 4). S.c. injection of vehicle did not produced any changes in thermal-
withdrawal latency. 
3.7 Thermal sensitivity after injection of mGluRs agonists 
S.c. injection of (s)-DHPG caused a dose-dependent decrease in withdrawal latencies on the 
ipsilateral side from 15 min to 6 h, but L-CCG-I and L-AP4 did not show any significant 
changes (Fig. 5).  
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Fig. 4. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of various concentration of the ionotropic glutamate receptor agonists; glutamate, 
NMDA and AMPA. The data for each group (at least 10 animals) are presented as the means 
± S.E.M. *P <0.05 significantly different from vehicle-treated group.  
 
Fig. 5. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of various concentration of the metabotropic glutamate receptor agonists;  (s)-
DHPG, L-CCG-I and L-AP4. The data for each group (at least 10 animals) are presented as 
the means ± S.E.M. *P <0.05 significantly different from vehicle-treated group.  
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3.8 Effect of iGluRs antagonists injection on capsaicin-induced thermal 
hypersensitivity  
When MK801 or CNQX were injected together with capsaicin (Cap+MK801 or Cap+CNQX), 
a dose-dependent increase in withdrawal latency was observed. These analgesic effects of 
MK801 or CNQX on capsaicin-induced thermal hyperalgesia lasted for more than 6 h (Fig. 
6). The single injection of MK801 or CNQX into the hindpaw did not show changes in 
withdrawal latencies compared to vehicle injection. 
 
Fig. 6. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of capsaicin in combination with the ionotropic glutamate receptor antagonists; 
MK801 and CNQX. The data for each group (at least 10 animals) are presented as the means 
± S.E.M. *P <0.05 significantly different from capsaicin (3 mM)-treated group. 
3.9 Effect of mGluRs antagonists injection on capsaicin-induced thermal 
hypersensitivity 
Following s.c. injection of CPCCOEt (5 mM), MPEP (30 mM), MCCG (5 mM), and MSOP (5 
mM) into hindpaw, there was no changes in withdrawal latencies compared to vehicle 
injection (Figs. 7 and 8). When CPCCOEt or MPEP were injected together with capsaicin 
(Cap+CPCCOEt or Cap+MPEP), withdrawal latencies showed a dose-dependent increase 
from 15 min to 2~3 h after the injection compared with when capsaicin was injected alone 
(P<0.05) (Fig. 7). The heat insensitivity evoked in ipsilateral side following Cap+CPCCOEt 
and Cap+MPEP injection continued for 5 h or more. S.c. injection of MCCG or MSOP 
combined with capsaicin did not show any significant changes in withdrawal latencies 
compared to capsaicin injection alone (Fig. 8). 
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Fig. 7. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of capsaicin in combination with the metabotropic glutamate receptor antagonists; 
CPCCOEt and MPEP. The data for each group (at least 10 animals) are presented as the 
means ± S.E.M. *P <0.05 significantly different from capsaicin (3 mM)-treated group. 
 
Fig. 8. Time course of withdrawal latencies in response to noxious heat stimulation after s.c. 
injection of capsaicin in combination with the metabotropic glutamate receptor antagonists; 
MCCG and MSOP. The data for each group (at least 10 animals) are presented as the means 
± S.E.M 
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3.10 Basal c-Fos expression in dorsal horn after injection of vehicle, capsaicin and 
Glu into hindpaw 
Immunoreactivity for c-Fos appeared gray-to-black and homogeneously labeled the oval or 
roundish nucleus of cells in spinal dorsal horn at L5 (Figs. 9-11). In all the experimental tests 
with injection of Glu, the maximum number of labeled cells occurred consistently in laminae 
I and II (I/II) of the spinal dorsal horn on the ipsilateral side (mean number ± S.E.M.=268 ± 
21) (Figs. 9-11 and Table 1). Much smaller number of c-Fos immunopositive cells occurred in 
lamine III and IV (III/IV, 30 ± 7). The capsaicin-induced c-Fos expression in laminae I/II 
(489 ± 34) and laminae III/IV (63 ± 18) on the ipsilateral side was greater than that with Glu 
(Figs. 9, 10 and Table 1). The numbers of c-Fos-immunopositive cells on the contralateral 
side was modest either with glutamate (I/II, 16 ± 7; III/IV, 12 ± 6) or capsaicin (I/II, 44 ± 13; 
III/IV, 20 ± 9). In animals administered with vehicle, c-Fos-immunopositive cells were rarely 
distributed either in laminae I/II (60 ± 5) or in laminae III/IV (22 ± 8) on the ipsilateral side 
or on the contralateral side (I/II, 12 ± 4; III/IV, 7 ± 2) (Table 1).  
 
 
Fig. 9. Photomicrographs showing c-Fos-positive neurons in the dorsal horn of L5 2 h after 
hindpaw injection of vehicle and glutamate. A and C: ipisilateral side. B and D: contralateral 
side. Solid line indicates 100 μm. 
3.11 Effects of ionotropic Glu receptors antagonists injection on the capsaicin-
induced c-Fos expression 
Few c-Fos-immunopositive cells were found in laminae I/II and laminae III/IV of the 
ipsilateral dorsal horn after each single injection of ionotropic Glu receptors antagonists 
MK-801 (I/II, 79 ± 3; III/IV, 11 ± 7) and CNQX (I/II, 70 ± 8; III/IV, 7 ± 3) similar to vehicle 
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injection (I/II, 60 ± 5; III/IV, 22 ± 8). The numbers of capsaicin-induced c-Fos-
immunopositive cells in laminae I/II (489 ± 34), but not in laminae III/IV (63 ± 18), were 
significantly decreased (P<0,005), when MK801 and CNQX were injected with capsaicin 
(Cap+MK801, I/II, 227 ± 32, III/IV, 14 ± 4; Cap+CNQX, I/II, 205 ± 40, III/IV, 11 ± 7) (Fig. 10 
and Table 1). The numbers of capsaicin-induced c-Fos-immunopositive cells on the 
contralateral sides did not significantly change by any of drugs with/without capsaicin.  
 
 
 
Fig. 10. Photomicrographs showing c-Fos-positive neurons in the dorsal horn of L5 2 h after 
hindpaw injection of capsaicin alone (A, B), combined with MK801 (C), and combined with 
MK801 CNQX (D). A, C and D: ipisilateral side. B: contralateral side. Solid line indicates  
100 μm. 
3.12 Effects of metabotropic glu antagonists injeection on the capsaicin-induced c-
Fos expression 
Few c-Fos-immunopositive cells in the ipsilateral laminae I/II and III/IV, and fewer cells in 
the contralateral sides, were observed with single injection of CPCCOEt (I/II, 59 ± 8, III/IV, 
1 ± 1), MCCG (I/II, 63 ± 10, III/IV, 3 ± 2) and MSOP (I/II, 66 ± 16, III/IV, 5 ± 3). Co-injection 
of CPCCOEt with capsaicin (Cap+CPCCOEt) significantly decreased the number of 
capsaicin-induced c-Fos-immunopositive cells in the ipsilateral laminae I/II (236 ± 58), but 
not in laminae III/IV (6 ± 4) and contralateral laminae I/II and III/IV. There was no 
significant change in the number of c-Fos-immunopositive cells in the ipsilateral laminae 
I/II, and III/IV by administration of MCCG combined with capsaicin (Cap+MCCG) or by 
administration of MSOP combined with capsaicin (Cap+MSOP; I/II, 383 ± 21, III/IV, 22 ± 3) 
compared to single injection of capsaicin, respectively (Fig. 11 and Table 1).  
www.intechopen.com
 Pharmacology  
 
56
 
Fig. 11. Photomicrographs showing c-Fos-positive neurons in the dorsal horn of L5 2 h after 
hindpaw injection of capsaicin alone (A), combined with CPCCOEt (B), with MCCG (C), 
with MSOP (D). A, B, C and D: ipisilateral side. Solid line indicates 100 μm . 
 
Table 1. Mean value of c-Fos-positive neurons in the dorsal horn of L5 2 h after s.c. injection 
of Glu receptors agonists and antagonists. The value in each group was represented mean ± 
S.E.M. obtained from at least 10 animals, and the difference of the means was analyzed with 
the Student’s t-test. * Significant difference at P< 0.05 between vehicle and capsaicin, or 
glutamate-treated group. # Significant difference at P< 0.05 between capsaicin and 
capsaicin+MK801, or capsaicin+CNQX, or capsaicin+CPCCOEt-treated group 
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4. Discussion 
We confirmed a large release of Glu immediately after the introduction of the catheter, 
followed by a rapid decrease, like in our previous study (Yonehara et al., 1987; Yonehara et 
al., 1992; Yonehara et al., 1995). Insertion of the polyethylene tube into the s.c. space of the 
rat instep did not evoke any inflammatory responses such as extravasation (Yonehara et al., 
1995). All these data suggest that the basal levels of Glu in the s.c. perfusate were caused by 
neither acute noxious stimulation nor inflammation.  
Topical application of capsaicin cream to the instep evoked a marked increase in Glu level in 
the s.c. perfusate, similar to the results in our previous study (Jin et al., 2006). In addition, 
electrical stimulation of the sciatic nerve or noxious heat stimulation (50C) also caused an 
increase of Glu level in the s.c. space, and this capsaicin-evoked Glu release was 
significantly decreased by daily high-dose pretreatment with capsaicin for three consecutive 
days (Jin et al., 2006).  
The TRPV1 is located in a neurochemically heterogeneous population of small diameter 
primary afferent neurons (Tominaga et al., 1998). Furthermore, repeated exposure to high-
dose capsaicin selectively produces a prolonged influx of cations leading to desensitization 
of small-diameter sensory neurons to subsequent noxious stimulation (Yonehara et al., 1987; 
Lynn, 1990; Zhou et al., 1998; Caterina and Julius, 2001), while myelinated Afibers are 
insensitive to capsaicin (Jancso et al., 1977; Nagy et al., 1983; Michael and Priestly, 1999). 
These findings and the present results suggest that the activation of capsaicin-sensitive 
afferent fibers by capsaicin causes release of Glu from the peripheral endings via activation 
of peripheral TRPV1, particularly from those of small-diameter fibers possibly through a 
mechanism such as the axon-reflex pathway, or autocrine and/or paracrine. It is reasonable 
to speculate that axon-reflex mechanism is involved in capsaicin-induced Glu release 
observed in Figs. 1 and 2, as only nociceptive afferent fibers have the axon-reflex mechanism 
which is localized on superficial tissues exposed to noxious influences (Celander and 
Folkow, 1953).  
Amount of capsaicin-induced Glu release was remarkably decreased by concomitant 
administration of ionotropic Glu receptors antagonists; MK801 and NBQX, and mGluR I 
antagonist; CPCCOEt in the hindpaw, but not by administration of group II and III mGluR 
antagonist; MCCG and MSOP. These results suggest that peripheral ionotropic Glu 
receptors and group I mGluR appear to play a role in mediating capsaicin-evoked increases 
in Glu release. The Glu release through the activation of TRPV1 could then further activate 
ionotoropic Glu receptors and group I mGluR on the same neuronal terminal or adjacent 
neighboring peripheral terminals. In this connection, there were evidences supporting the 
co-localization of peripheral NMDA and TRPV1 receptors on the same primary afferent 
terminal (Lam et al., 2003; Lam et al., 2004). 
Activation of peripheral Glu receptors could lead to enhance the Glu release in the 
peripheral tissues and might alter TRPV1 receptor responsiveness to reinforce nociceptive 
responses. As it is necessary to investigate the interaction between TRPV1 and glutamate 
receptors by using specific receptor antagonists of TRPV1 in detail, the mechanism to 
account for the antagonism of peripheral Glu receptors contributes to inhibit capsaicin-
induced Glu release remains unanswered. However, it may be possible that glutamate 
receptors play a pivotal role for the activation of TRPV1 in the peripheral terminals. This 
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idea is supported by the results that the intraplantar injection of ionotoropic Glu receptors 
and group I mGluR agonists evoked dose-dependent thermal hyperalgesia. Moreover, it is 
very interesting to note that injection of Glu receptors antagonists alone did not produce any 
changes on withdrawal latency, and intraplantar co-injection of ionotropic Glu receptors 
and group I mGluR antagonists with capsaicin not only antagonized capsaicin-induced 
hyperalgesia, but also resulted in remarkable longer withdrawal latency to heat irradiation.  
Concerning the mechanism that ionotoropic Glu receptors and mGluR antagonists 
produced remarkable analgesic action in the presence of capsaicin, there is evidence that 
capsaicin injected into the rat temporomandibular joint evoked a dose-dependent increase in 
jaw muscle electromyographic activity. This capsaicin-evoked increase in electromyographic 
activity was attenuated by ipsilateral injection of NMDA receptor antagonists into the 
temporomandibular joint (Lam et al. 2005). This finding and our present results indicate that 
the activation of peripheral Glu receptors, especially ionotropic Glu receptors and group I 
mGluR could be indispensable in the mechanisms whereby capsaicin evokes nociceptive 
responses.  
The ionotropic, and metabotropic subunits of Glu receptors are present in DRG cell bodies 
and on unmyelinated fibers in the glabrous skin of the mammalian foot (Carlton et al., 1995; 
Bhave et al., 2001; Carlton et al., 2001; Sato et al., 1993; Carlton et al., 2007). It is well 
established that the excitatory amino acids in the peripheral endings of small-diameter 
afferent fibers contribute to development and/or maintenance of pain in humans (Nordlind 
et al., 1993; Warncke et al., 1997) and in laboratory animals (Davidson et al., 1997; Cairns et 
al., 1998; Davidson et al., 1998). For example, peripherally applied NMDA and non-NMDA 
receptor antagonists attenuate or block nociceptive behaviors in several animal models of 
inflammation (Jackson et al., 1995; Lawand et al., 1997; Carlton et al., 1998).  
In the present study, we examined the c-Fos expression in spinal cord dorsal horn following 
injection of drugs associated with glutamate receptors with/without capsaicin into the 
hindpaw. c-Fos is rapidly and transiently induced in cells of the spinal dorsal horn after 
noxious stimulation (Hunt et al., 1987, Strassman and Vos, 1993, Takemura et al., 2000), c-
Fos has been widely used as a marker for analyzing nociceptive processing.  
Our present data support the view that Glu receptors, in particular, ionotropic Glu receptors 
and group I mGluR existing in peripheral ending of capsaicin-sensitive afferent fibers play 
an important role on development and/or maintenance of pain following excitation of 
TRPV1. In addition, the formulation of the peripheral ionotoropic Glu receptors and group I 
mGluR antagonists that do not cross the blood brain barrier may be of potential benefit by 
reducing peripheral nociceptive excitability, and therefore they could provide a new 
therapeutic target to pain control in the periphery.  
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